HCA released a preview of its second-quarter financials, predicting income before taxes would rise more than 15 percent to $806 million, compared with $699 million in the second quarter of 2012. Revenue is expected to top $8.45 billion in the second quarter, ended June 30, while adjusted EBITDA will be approximately $1.69 billion.
Same-facility admissions are predicted to have increased 1.3 percent in the most recent quarter, bucking trends from the first quarter of this year, which prompted HCA executives to reaffirm its financial targets for 2013.
HCA plans on releasing full second-quarter financials Aug. 1.
More Articles on HCA:
For-Profit Hospital Stock Report: Week of July 8-12, 2013
HCA’s $65M Poinciana Medical Center to Open Soon
Report: CHS, HCA, LifePoint Interested in Buying HMA
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
